Article

Proteomic analysis of cerebrospinal fluid of amyotrophic lateral sclerosis patients in the presence of autologous bone marrow derived mesenchymal stem cells

2023-12-07

Abstract excerpt

<title>Abstract</title> <p>Background Amyotrophic lateral sclerosis (ALS) is a fatal and fast progressive motoneuron degenerative disorder. There are still no drugs capable to slower disease evolution or to improve life quality of ALS patients. In that scenario, the cell therapy has emerged as an alternative to be investigated in clinical ALS. Method Taking the advantage of Proteomics and Protein-Protein Intera...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e04461e0-3b5c-50bf-9092-e6843fdd05b8
DOI: 10.21203/rs.3.rs-3665197/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Proteomic analysis of cerebrospinal fluid of amyotrophic lateral sclerosis patients in the presence of autologous bone marrow derived mesenchymal stem cellsDOI 10.21203/rs.3.rs-3665197/v1Read

Proteomic studies in the discovery of cerebrospinal fluid biomarkers for amyotrophic lateral sclerosisSemantic proximity Read

Network Analysis of the Cerebrospinal Fluid Proteome Reveals Shared and Unique Differences Between Sporadic and Familial Forms of Amyotrophic Lateral SclerosisSemantic proximity Read

Plasma profiling reveals three proteins associated to amyotrophic lateral sclerosisSemantic proximity Read

Analysis of Circulating Protein Aggregates Reveals Pathological Hallmarks of Amyotrophic Lateral SclerosisSemantic proximity Read

Small peptide fingerprint (peptidomics) of Amyotrophic Lateral Sclerosis in CSFSemantic proximity Read

Analysis of circulating protein aggregates reveals pathological hallmarks of amyotrophic lateral sclerosisSemantic proximity Read

Muscle proteins in plasma associate to distinguished phenotypes in amyotrophic lateral sclerosisSemantic proximity Read

Proteomic profiling of CSF reveals stage-specific changes in Amyotrophic lateral sclerosis patientsSemantic proximity Read

The Need for Biomarkers in the ALS–FTD Spectrum: A Clinical Point of View on the Role of ProteomicsSemantic proximity Read

Network analysis of the cerebrospinal fluid proteome reveals shared and unique differences between sporadic and familial forms of amyotrophic lateral sclerosisSemantic proximity Read

Multi-Omics for Biomarker Discovery and Target Validation in Biofluids for Amyotrophic Lateral Sclerosis DiagnosisSemantic proximity Read

Combined Tissue-Fluid Proteomics to Unravel Phenotypic Variability in Amyotrophic Lateral SclerosisSemantic proximity Read